Clinical Trial Update: Treatment of Unresecable and/or Metastatic Merkel Cell Carcinoma by Somatostatine Analogues [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating somatostatin analogues for unresectable and/or metastatic Merkel cell carcinoma; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Merkel Cell Carcinoma

Drugs mentioned

• Somatostatin analogue (somatostatin analogue)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Carcinoma, Merkel Cell | Phase 2 | Status: COMPLETED